Interaction of iC3b with recombinant isotypic and chimeric forms of CR2
- PMID: 1830068
Interaction of iC3b with recombinant isotypic and chimeric forms of CR2
Abstract
CR2 is a component of a signal transduction complex on B lymphocytes that augments B cell responses to Ag. We have quantitatively assessed binding by the two isotypic forms of CR2 for two of its ligands, the polymerized iC3b (p(iC3b)) fragment of C3, and gp350/220, the EBV membrane protein. The recombinant 15-SCR or 16-SCR forms of CR2 bound p(iC3b) with identical affinities. Full binding activity of CR2 for p(iC3b) was observed with a chimera comprised of SCR-1 and -2 of CR2 fused to SCR-17 through -30 of CR1. Therefore, the alternatively spliced SCR-10a has no role in binding p(iC3b), and the binding activity of wild type receptor for iC3b can be reconstituted with SCR-1 and -2 of CR2. The binding affinities of the two isoforms of CR2 for soluble gp350/220 were also similar. Additional sites in the C3c region of C3 have been postulated also to interact with CR2. However, monomeric iC3b and C3d were equally effective in inhibiting the binding of p(iC3b) to CR2, indicating that the C3c region of iC3b does not contribute to the interaction of iC3b with CR2. Finally, the relative abilities of C3b and iC3b to bind to CR1 and CR2 were compared. The conversion of C3b to iC3b generated a ligand with an approximate 100-fold decrease in affinity for CR1 and a 10-fold increased affinity for CR2, resulting in a 1000-fold greater likelihood for binding to the latter receptor that may then promote B cell activation.
Similar articles
-
Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).Eur J Immunol. 1991 Nov;21(11):2829-38. doi: 10.1002/eji.1830211126. Eur J Immunol. 1991. PMID: 1834472
-
Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.J Immunol. 1985 Apr;134(4):2571-9. J Immunol. 1985. PMID: 3156185
-
Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.J Immunol. 1995 Mar 1;154(5):2303-20. J Immunol. 1995. PMID: 7868901
-
Structure and signalling functions of C3 receptors on human B cells.Semin Immunol. 1990 Mar;2(2):159-64. Semin Immunol. 1990. PMID: 2151800 Review.
-
Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).Immunodefic Rev. 1990;2(1):17-41. Immunodefic Rev. 1990. PMID: 2164822 Review.
Cited by
-
Structure, functions, and evolution of the third complement component and viral molecular mimicry.Immunol Res. 1998;17(1-2):109-21. doi: 10.1007/BF02786436. Immunol Res. 1998. PMID: 9479573 Review.
-
Trypanosomes and complement: more than one way to die?Trends Parasitol. 2023 Dec;39(12):1014-1022. doi: 10.1016/j.pt.2023.09.001. Epub 2023 Sep 25. Trends Parasitol. 2023. PMID: 37758633 Free PMC article. Review.
-
Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350.J Virol. 2008 Nov;82(22):11217-27. doi: 10.1128/JVI.01673-08. Epub 2008 Sep 10. J Virol. 2008. PMID: 18786993 Free PMC article.
-
Complement System Part I - Molecular Mechanisms of Activation and Regulation.Front Immunol. 2015 Jun 2;6:262. doi: 10.3389/fimmu.2015.00262. eCollection 2015. Front Immunol. 2015. PMID: 26082779 Free PMC article. Review.
-
The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes.Infect Immun. 2011 Apr;79(4):1559-65. doi: 10.1128/IAI.01036-10. Epub 2011 Jan 18. Infect Immun. 2011. PMID: 21245264 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous